These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. The association of estrogen replacement therapy and the Raynaud phenomenon in postmenopausal women. Fraenkel L; Zhang Y; Chaisson CE; Evans SR; Wilson PW; Felson DT Ann Intern Med; 1998 Aug; 129(3):208-11. PubMed ID: 9696729 [TBL] [Abstract][Full Text] [Related]
3. A vascular mechanistic approach to understanding Raynaud phenomenon. Flavahan NA Nat Rev Rheumatol; 2015 Mar; 11(3):146-58. PubMed ID: 25536485 [TBL] [Abstract][Full Text] [Related]
4. Minimally invasive treatment of Raynaud phenomenon: the role of botulinum type A. Neumeister MW; Webb KN; Romanelli M Hand Clin; 2014 Feb; 30(1):17-24. PubMed ID: 24286738 [TBL] [Abstract][Full Text] [Related]
5. [Serum endothelin in patients with Raynaud syndrome before and following cold provocation]. von Bierbrauer A; Herzog U; Ehlenz K; Wichert P Vasa Suppl; 1991; 33():156-7. PubMed ID: 1788654 [TBL] [Abstract][Full Text] [Related]
6. Cerebral artery vasoconstriction and the Raynaud phenomenon. Trapp RG Ann Intern Med; 1987 Apr; 106(4):630. PubMed ID: 3826964 [No Abstract] [Full Text] [Related]
7. Exaggerated postural vasoconstrictor reflex in Raynaud's phenomenon. Chant AD Br Med J (Clin Res Ed); 1987 Jul; 295(6589):51. PubMed ID: 3113611 [No Abstract] [Full Text] [Related]
8. [Effect of obliteration of the subclavian artery on peripheral vasoconstriction; formation of a syndrome similar to Raynaud disease and 30 years follow-up of resection of the obliterated segment]. LERICHE R Lyon Chir; 1952; 47(8):913-6. PubMed ID: 13036242 [No Abstract] [Full Text] [Related]
9. The role of botulinum toxin in vasospastic disorders of the hand. Neumeister MW Hand Clin; 2015 Feb; 31(1):23-37. PubMed ID: 25455354 [TBL] [Abstract][Full Text] [Related]
10. Endothelin, vasoconstriction, and endothelial damage in Raynaud's phenomenon. Cimminiello C; Milani M; Uberti T; Arpaia G; Perolini S; Bonfardeci G Lancet; 1991 Jan; 337(8733):114-5. PubMed ID: 1670699 [No Abstract] [Full Text] [Related]
12. Fat grafting to the hand in patients with Raynaud phenomenon: a novel therapeutic modality. Bank J; Fuller SM; Henry GI; Zachary LS Plast Reconstr Surg; 2014 May; 133(5):1109-1118. PubMed ID: 24445877 [TBL] [Abstract][Full Text] [Related]
13. [Physiopathology of Raynaud's phenomenon]. Bollinger A Dtsch Med Wochenschr; 1982 Nov; 107(45):1699-701. PubMed ID: 7140547 [No Abstract] [Full Text] [Related]
17. No significant effect of ginkgo biloba special extract EGb 761 in the treatment of primary Raynaud phenomenon: a randomized controlled trial. Bredie SJ; Jong MC J Cardiovasc Pharmacol; 2012 Mar; 59(3):215-21. PubMed ID: 22030896 [TBL] [Abstract][Full Text] [Related]